Chase AIPricingFAQs
Display currency
Loading news…

Rheos Medicines

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Cambridge, Massachusetts, United States Founded 2017 11-50 employees For Profit

A biopharmaceutical company developing novel medicines that modulate metabolic pathways in immune cells to treat disease.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
31

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private
Valuation range
$100M to $500M

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
10

Company Info

Founded
2017
Employees
11-50
Operating status
Active
Company type
For Profit
Org types
company
Founders
2
News articles
27
HQ
Cambridge, Massachusetts, United States
Region
Greater Boston Area, East Coast, New England
Diversity spotlight
Women Founded; Women Led

Signals & Scores

Heat score
Low
Growth score
Low
Trend (7d)
-0.1
Trend (30d)
-0.4
Trend (90d)
0.1
Last leadership hire
Apr 14, 2022

Key People at Rheos Medicines

CEO
Vice President, Strategy & Business Development
31
professional contacts at Rheos Medicines
Contact execs at Rheos Medicines

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Rheos Medicines

Loading news…

FAQs about Rheos Medicines

People who checked this page also checked these

Browse the full Acquirezy directory.
Rheos Medicines - Company Profile, Full Acquisitions List, Funding and Investments